^
    Apply
    A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer (NCT02316509)
    Phase 1
    Genentech, Inc.
    Completed
    Last update posted :
    10/05/2020
    Initiation :
    03/17/2015
    Primary completion :
    01/10/2020
    Completion :
    01/10/2020
    HER-2 • ER
    |
    ER positive • HER-2 negative
    |
    GDC-0927